Pharma & Biopharma

Immunotherapy unmasked: Raman spectroscopy combined with machine learning predicts non-responders to immunotherapy

Biopharmaceutical development is in need of a speed boost. Multi-omics could be the answer.

In pharmaceutical quality management; consistency, flexibility, responsiveness, and experience are key

A husband-and-wife-led team used mass spec to identify new drugs that “glue” proteins together. We spoke to Aneika Leney about the project.

Here, we present the results of the Pharma Analysis & Quality Control Trends, Challenges and Outlook 2021 Global Survey.

An MS-based algorithm could transform natural product drug discovery

Gas generation presents a safer, more cost-effective, and more reliable alternative to traditional tanks – is it time you made the switch?

What makes native LC-MS so powerful when it comes to biopharmaceutical analysis?

A 70-year-old technique is helping to cut the development costs of monoclonal antibodies.

Anna Cousens, Global Analytical BDM at Almac Sciences, discusses ICP-MS analysis and the importance of getting it right in drug development